Jin Liu1, Gu Weiling2, Li Xueqin1, Xie Liang1, Wang Linhong1, Chen Zhongwen3. 1. Department of Control and Prevention of Chronic Non-communicable Diseases, Jiaxing Center for Disease Control and Prevention, Jiaxing, Zhejiang, 314050, China. 2. Office, Jiaxing Center for Disease Control and Prevention, No.486 Wenqiao Road, Jiaxing, Zhejiang, 314050, China. 3. Office, Jiaxing Center for Disease Control and Prevention, No.486 Wenqiao Road, Jiaxing, Zhejiang, 314050, China. chenzhongww21@163.com.
Abstract
OBJECTIVES: We performed an updated meta-analysis to clarify the relationship between the CEBPE rs2239633 polymorphism and the childhood acute lymphoblastic leukemia (CALL) susceptibility. METHODS: All the case-control studies were updated on October 5, 2020, through Web of Science, PubMed, Cochrane Library, Embase, and China National Knowledge Infrastructure (CNKI) electronic database. The heterogeneity in the study was tested by the Q test and I2, and then the random ratio or fixed effect was utilized to merge the odds ratios (OR) and 95% confidence interval (CI). We also performed sensitivity analysis to estimate the impact of individual studies on aggregate estimates. Publication bias was investigated by using funnel plot and Egger's regression test. All statistical analyses were performed using Stata 12.0. RESULTS: A total of 20 case-control studies were selected, including 7014 patients and 16,428 controls. There was no association of CEBPE rs2239633 polymorphism with CALL (CC vs CT + TT: OR = 1.08, 95% CI = 0.94-1.26; CC + CT vs TT: OR = 1.10, 95% CI = 0.94-1.30; C vs T: OR = 1.02, 95% CI = 0.92-1.13). In the subgroup analysis by ethnicity, there is no significant association of this polymorphism and CALL risks among Asian and Caucasian populations in the three genetic models (CC vs CT + TT, CC + CT vs TT, and C vs T). CONCLUSION: This meta-analysis found no significant association between the CEBPE rs2239633 polymorphism and susceptibility to CALL.
OBJECTIVES: We performed an updated meta-analysis to clarify the relationship between the CEBPErs2239633 polymorphism and the childhood acute lymphoblastic leukemia (CALL) susceptibility. METHODS: All the case-control studies were updated on October 5, 2020, through Web of Science, PubMed, Cochrane Library, Embase, and China National Knowledge Infrastructure (CNKI) electronic database. The heterogeneity in the study was tested by the Q test and I2, and then the random ratio or fixed effect was utilized to merge the odds ratios (OR) and 95% confidence interval (CI). We also performed sensitivity analysis to estimate the impact of individual studies on aggregate estimates. Publication bias was investigated by using funnel plot and Egger's regression test. All statistical analyses were performed using Stata 12.0. RESULTS: A total of 20 case-control studies were selected, including 7014 patients and 16,428 controls. There was no association of CEBPErs2239633 polymorphism with CALL (CC vs CT + TT: OR = 1.08, 95% CI = 0.94-1.26; CC + CT vs TT: OR = 1.10, 95% CI = 0.94-1.30; C vs T: OR = 1.02, 95% CI = 0.92-1.13). In the subgroup analysis by ethnicity, there is no significant association of this polymorphism and CALL risks among Asian and Caucasian populations in the three genetic models (CC vs CT + TT, CC + CT vs TT, and C vs T). CONCLUSION: This meta-analysis found no significant association between the CEBPErs2239633 polymorphism and susceptibility to CALL.
Authors: L Orsi; J Rudant; A Bonaventure; S Goujon-Bellec; E Corda; T-J Evans; A Petit; Y Bertrand; B Nelken; A Robert; G Michel; N Sirvent; P Chastagner; S Ducassou; X Rialland; D Hémon; E Milne; R J Scott; A Baruchel; J Clavel Journal: Leukemia Date: 2012-06-04 Impact factor: 11.528
Authors: K M Walsh; A P Chokkalingam; L-I Hsu; C Metayer; A J de Smith; D I Jacobs; G V Dahl; M L Loh; I V Smirnov; K Bartley; X Ma; J K Wiencke; L F Barcellos; J L Wiemels; P A Buffler Journal: Leukemia Date: 2013-04-25 Impact factor: 11.528
Authors: Tadayuki Akagi; Nils H Thoennissen; Ann George; Gay Crooks; Jee Hoon Song; Ryoko Okamoto; Daniel Nowak; Adrian F Gombart; H Phillip Koeffler Journal: PLoS One Date: 2010-11-03 Impact factor: 3.240
Authors: Takashi Akasaka; Theodore Balasas; Lisa J Russell; Kei-ji Sugimoto; Aneela Majid; Renata Walewska; E Loraine Karran; David G Brown; Kelvin Cain; Lana Harder; Stefan Gesk; Jose Ignacio Martin-Subero; Mark G Atherton; Monika Brüggemann; María José Calasanz; Teresa Davies; Oskar A Haas; Anne Hagemeijer; Helena Kempski; Michel Lessard; Debra M Lillington; Sarah Moore; Florence Nguyen-Khac; Isabelle Radford-Weiss; Claudia Schoch; Stéphanie Struski; Polly Talley; Melanie J Welham; Helen Worley; Jon C Strefford; Christine J Harrison; Reiner Siebert; Martin J S Dyer Journal: Blood Date: 2006-12-14 Impact factor: 22.113
Authors: Elli Papaemmanuil; Fay J Hosking; Jayaram Vijayakrishnan; Amy Price; Bianca Olver; Eammon Sheridan; Sally E Kinsey; Tracy Lightfoot; Eve Roman; Julie A E Irving; James M Allan; Ian P Tomlinson; Malcolm Taylor; Mel Greaves; Richard S Houlston Journal: Nat Genet Date: 2009-08-16 Impact factor: 38.330